1. De Vriese, A. S., Glassock, R. J., Nath, K. A., Sethi, S. & Fervenza, F. C. A proposal for a serology-based approach to membranous nephropathy. J. Am. Soc. Nephrol. 28, 421–430 (2017).
2. Pozdzik, A. et al. Membranous nephropathy and anti-podocytes antibodies: implications for the diagnostic workup and disease management. Biomed. Res. Int. 2018, 6281054 (2018).
3. Moroni, G. & Ponticelli, C. Secondary membranous nephropathy. a narrative review. Front. Med. (Lausanne). 7, 611317 (2020).
4. Nagahama, K. et al. Bucillamine induces membranous glomerulonephritis. Am. J. Kidney Dis. 39, 706–712 (2002).
5. Hoshino, J. et al. Outcome and treatment of bucillamine-induced nephropathy. Nephron Clin. Pract. 104, c15–c19 (2006).
6. Rinschen, M. M., Limbutara, K., Knepper, M. A., Payne, D. M. & Pisitkun, T. From molecules to mechanisms: functional proteomics and its application to renal tubule physiology. Physiol. Rev. 98, 2571–2606 (2018).
7. Taherkhani, A., Farrokhi Yekta, R., Mohseni, M., Saidijam, M. & Arefi Oskouie, A. Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers. Proteome Sci. 17, 7 (2019).
8. Kawata, N. et al. Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry. Nephrology (Carlton). 25, 351–359 (2020).
9. Ravindran, A. et al. Proteomic analysis of complement proteins in membranous nephropathy. Kidney Int. Rep. 5, 618–626 (2020).
10. Kopp, J. B. et al. Podocytopathies. Nat. Rev. Dis. Primers. 6, 68 (2020).
11. Blaine, J. & Dylewski, J. Regulation of the actin cytoskeleton in podocytes. Cells. 9, 1700 (2020).
12. van Duijn, T. J., Anthony, E. C., Hensbergen, P. J., Deelder, A. M. & Hordijk, P. L. Rac1 recruits the adapter protein CMS/CD2AP to cell-cell contacts. J. Biol. Chem. 285, 20137–20146 (2010).
13. Zhang, W., Ren, Y. & Li, J. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy. Ren. Fail. 41, 704–717 (2019).
14. Zou, J. et al. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch. 448, 485–492 (2006).
15. Su, W. et al. Expression of nestin in the podocytes of normal and diseased human kidneys. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R1761–R1767 (2007).
16. Naylor, R. W., Morais, M. R. P. T. & Lennon, R. Complexities of the glomerular basement membrane. Nat. Rev. Nephrol. 17, 112–127 (2021).
17. Onetti Muda, A., Ruzzi, L., Bernardini, S., Teti, A. & Faraggiana, T. Collagen VII expression in glomerular sclerosis. J. Pathol. 195, 383–390 (2001).
18. Kinnunen, A. I. et al. Lack of collagen XVIII long isoforms affects kidney podocytes, whereas the short form is needed in the proximal tubular basement membrane. J. Biol. Chem. 286, 7755–7764 (2011).
19. Izadi, M., Hou, W., Qualmann, B. & Kessels, M. M. Direct effects of Ca 2+/calmodulin on actin filament formation. Biochem. Biophys. Res. Commun. 506, 355–360 (2018).
20. Meyer-Schwesinger, C. et al. Ubiquitin C-terminal hydrolase-L1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am. J. Physiol. 178, 2044–2057 (2011).
21. Kallio, H. et al. Characterization of non-specific cytotoxic cell receptor protein 1: a new member of the lectin-type subfamily of F-box proteins. PLoS One. 6, e27152 (2011).
22. van de Logt, A. E., Fresquet, M., Wetzels, J. F. & Brenchley, P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 96, 1292–1302 (2019).
23. Meyer-Schwesinger, C. The ubiquitin-proteasome system in kidney physiology and disease. Nat. Rev. Nephrol. 15, 393–411 (2019).
24. Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982–992 (2009).
25. Kaga, H. et al. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA. Clin. Exp. Nephrol. 23, 465–473 (2019).
26. Komatsuda, A. et al. Monoclonal immunoglobulin deposition disease associated with membranous features. Nephrol. Dial. Transplant. 23, 3888–3894 (2008).
27. Miyakawa, R. et al. Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice. Clin. Exp. Nephrol. 24, 666–679 (2020).
28. Gastinel, L. N. Principle component analysis in the era of <<omics>> data in Principle component analysis - Multidisciplinary applications (ed. Sanguansat, P.) 21–42 (InTech, 2012).